Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
Local call local switching at handover
Produce container and lid assembly
Secure mobile ad hoc network
Image sensor and method for fabricating the same
Semiconductor pressure sensor
Triazine ring-containing polymer and film-forming composition comprising same
Method and system for reciprocal mixing cancellation of wideband modulated blockers
  Randomly Featured Patents
Can supported ashtray
Apparatus and method of driving high-efficiency plasma display panel
Pyridyl derivatives and their use as therapeutic agents
Lubricating device and method
Electric motor
Sweet orange tree named `N7-3`
Signaling inositol polyphosphate 5-phosphatases (SIPs)
Sleeve-type floral grouping wrapper
Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria
Step chain for curved escalator